Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01573338
Show Display Options
Rank Status Study
1 Active, not recruiting Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Smal Cell Lung Cancer)
Condition: Small Cell Lung Carcinoma
Interventions: Drug: Roniciclib (BAY 1000394);   Drug: Etoposide;   Drug: Cisplatin;   Drug: Carboplatin

Indicates status has not been verified in more than two years